Lihui Wei

596 citations
24 papers · 478 indexed · h-index 12
Topics
Natural product bioactivities and synthesis (5 papers)Hedgehog Signaling Pathway Studies (4 papers)Bioactive Compounds and Antitumor Agents (3 papers)

In The Last Decade

Lihui Wei

22 papers receiving 472 citations

Peers

Lihui Wei
Comparison fields: 5 of 70
  • Molecular Biology 332
  • Oncology 95
  • Pharmacology 67
  • Plant Science 65
  • Cancer Research 64
Replace Shu Chun Hsu with:
Shu Chun Hsu Taiwan
Chin Cheng Su Taiwan
Meng‐Liang Lin Taiwan
Mu‐Yang Huang Macao
Young‐Rak Cho South Korea
Xiao-Huang Xu Macao
Sang‐Mi Woo South Korea
Ching-Lung Liao Taiwan
Xuan‐Run Wang Macao
Benedikt Giessrigl Austria
Lihui Wei relative to Shu Chun Hsu Taiwan Shu Chun Hsu's profile →
Citations per field
00.5×2.7×
Shu Chun Hsu · 1×
Citations per year

Countries citing papers authored by Lihui Wei

Since Specialization
Citations

This map shows the geographic impact of Lihui Wei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lihui Wei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lihui Wei more than expected).

Fields of papers citing papers by Lihui Wei

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lihui Wei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lihui Wei. The network helps show where Lihui Wei may publish in the future.

Co-authorship network of co-authors of Lihui Wei

This figure shows the co-authorship network connecting the top 25 collaborators of Lihui Wei. A scholar is included among the top collaborators of Lihui Wei based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lihui Wei. Lihui Wei is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 0
3 1
4 1
5 6
6 10
7 16
8 8
9 6
10 0
11 34
12 35
13 42
14 18
15 75
16 32
17 60
18 63
19 15
20
Role of phosphatase PTEN in the activation of extracellular signal-regulated kinases induced by estradiol in endometrial carcinoma cells.
6

About Lihui Wei

Lihui Wei is a scholar working on Toxicology, Molecular Biology and Cancer Research, having authored 24 papers that have together received 478 indexed citations. Recurring topics across this work include Natural product bioactivities and synthesis (5 papers), Hedgehog Signaling Pathway Studies (4 papers) and Bioactive Compounds and Antitumor Agents (3 papers). The work is most often cited by research in Toxicology (36 citations), Applied Microbiology and Biotechnology (14 citations) and Pharmacology (56 citations). Lihui Wei has collaborated with scholars based in China, United States and Australia. Frequent co-authors include Jun Peng, Jiumao Lin, Aling Shen, Zhenfeng Hong, Youqin Chen, Thomas J. Sferra, Wei Xu, Qiaoyan Cai, Li Li and Guodong Sun. Their work appears in journals such as PLoS ONE, Scientific Reports and International Journal of Molecular Sciences.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026